基于人工智能的多模态数据痴呆病因鉴别诊断。

IF 58.7 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Nature Medicine Pub Date : 2024-07-04 DOI:10.1038/s41591-024-03118-z
Chonghua Xue, Sahana S Kowshik, Diala Lteif, Shreyas Puducheri, Varuna H Jasodanand, Olivia T Zhou, Anika S Walia, Osman B Guney, J Diana Zhang, Serena T Pham, Artem Kaliaev, V Carlota Andreu-Arasa, Brigid C Dwyer, Chad W Farris, Honglin Hao, Sachin Kedar, Asim Z Mian, Daniel L Murman, Sarah A O'Shea, Aaron B Paul, Saurabh Rohatgi, Marie-Helene Saint-Hilaire, Emmett A Sartor, Bindu N Setty, Juan E Small, Arun Swaminathan, Olga Taraschenko, Jing Yuan, Yan Zhou, Shuhan Zhu, Cody Karjadi, Ting Fang Alvin Ang, Sarah A Bargal, Bryan A Plummer, Kathleen L Poston, Meysam Ahangaran, Rhoda Au, Vijaya B Kolachalama
{"title":"基于人工智能的多模态数据痴呆病因鉴别诊断。","authors":"Chonghua Xue, Sahana S Kowshik, Diala Lteif, Shreyas Puducheri, Varuna H Jasodanand, Olivia T Zhou, Anika S Walia, Osman B Guney, J Diana Zhang, Serena T Pham, Artem Kaliaev, V Carlota Andreu-Arasa, Brigid C Dwyer, Chad W Farris, Honglin Hao, Sachin Kedar, Asim Z Mian, Daniel L Murman, Sarah A O'Shea, Aaron B Paul, Saurabh Rohatgi, Marie-Helene Saint-Hilaire, Emmett A Sartor, Bindu N Setty, Juan E Small, Arun Swaminathan, Olga Taraschenko, Jing Yuan, Yan Zhou, Shuhan Zhu, Cody Karjadi, Ting Fang Alvin Ang, Sarah A Bargal, Bryan A Plummer, Kathleen L Poston, Meysam Ahangaran, Rhoda Au, Vijaya B Kolachalama","doi":"10.1038/s41591-024-03118-z","DOIUrl":null,"url":null,"abstract":"<p><p>Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an artificial intelligence (AI) model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51,269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a microaveraged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the microaveraged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two co-occurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in clinical settings and drug trials. Further prospective studies are needed to confirm its ability to improve patient care.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":null,"pages":null},"PeriodicalIF":58.7000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AI-based differential diagnosis of dementia etiologies on multimodal data.\",\"authors\":\"Chonghua Xue, Sahana S Kowshik, Diala Lteif, Shreyas Puducheri, Varuna H Jasodanand, Olivia T Zhou, Anika S Walia, Osman B Guney, J Diana Zhang, Serena T Pham, Artem Kaliaev, V Carlota Andreu-Arasa, Brigid C Dwyer, Chad W Farris, Honglin Hao, Sachin Kedar, Asim Z Mian, Daniel L Murman, Sarah A O'Shea, Aaron B Paul, Saurabh Rohatgi, Marie-Helene Saint-Hilaire, Emmett A Sartor, Bindu N Setty, Juan E Small, Arun Swaminathan, Olga Taraschenko, Jing Yuan, Yan Zhou, Shuhan Zhu, Cody Karjadi, Ting Fang Alvin Ang, Sarah A Bargal, Bryan A Plummer, Kathleen L Poston, Meysam Ahangaran, Rhoda Au, Vijaya B Kolachalama\",\"doi\":\"10.1038/s41591-024-03118-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an artificial intelligence (AI) model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51,269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a microaveraged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the microaveraged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two co-occurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in clinical settings and drug trials. Further prospective studies are needed to confirm its ability to improve patient care.</p>\",\"PeriodicalId\":19037,\"journal\":{\"name\":\"Nature Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":58.7000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41591-024-03118-z\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-024-03118-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

由于不同病因导致的症状重叠,痴呆症的鉴别诊断仍然是神经病学的一项挑战,但它对于制定早期个性化管理策略至关重要。在此,我们介绍一种人工智能(AI)模型,该模型利用广泛的数据,包括人口统计学、个人和家庭病史、药物使用、神经心理学评估、功能评估和多模态神经影像学,来识别导致个人痴呆症的病因。这项研究利用了 9 个独立的不同地域数据集的 51269 名参与者,帮助确定了 10 种不同的痴呆病因。它将诊断与类似的管理策略结合起来,确保即使在数据不完整的情况下也能做出可靠的预测。我们的模型在对认知正常、轻度认知障碍和痴呆症患者进行分类时,接收者操作特征曲线下的微观平均面积(AUROC)达到了 0.94。此外,在区分痴呆病因方面,微平均接受者操作特征曲线下面积(AUROC)为 0.96。我们的模型在处理混合型痴呆病例方面表现出了很高的能力,对两种并发病症的平均 AUROC 为 0.78。在随机选取的 100 个病例子集中,经我们的人工智能模型增强的神经学家评估的 AUROC 比仅由神经学家进行的评估高出 26.25%。此外,我们的模型预测与生物标志物证据相一致,其与不同蛋白病的关联也通过尸检结果得到了证实。我们的框架有可能在临床环境和药物试验中被整合为痴呆症的筛查工具。还需要进一步的前瞻性研究来证实其改善患者护理的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
AI-based differential diagnosis of dementia etiologies on multimodal data.

Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an artificial intelligence (AI) model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51,269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a microaveraged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the microaveraged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two co-occurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in clinical settings and drug trials. Further prospective studies are needed to confirm its ability to improve patient care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
期刊最新文献
Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction Patient attitudes toward the AI doctor Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial A toolbox for surfacing health equity harms and biases in large language models High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1